Cointime

Perseus-Soros Biopharmaceutical Fund

investment firm

About

Perseus-Soros Biopharmaceutical Fund, L.P. specializes in equity investments in private and public life science companies.

  • New York,New York,United States

Highlights

Investments
22
Lead Investments
5
Exits
9

Details

Operating Status
Active
Investor Type
PE

Funds Raised

Announced Date Fund Name Money Raised
Jan 1, 2000 Perseus-Soros BioPharmaceutical Fund $449M

Investments

Number of Investments
Number of Lead Investments
22
5
Perseus-Soros Biopharmaceutical Fund has made 22 investments. Their most recent investment was on Oct 30, 2009, when Xanodyne raised $87.78M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 30, 2009 Xanodyne
Series Unknown $87.78M Biotechnology —
Sep 29, 2008 CeNeRx BioPharma
Series B $15M Biopharma —
Nov 14, 2007 Ambit Biosciences
Series D $49.30M Biopharma —
May 1, 2006 Cardiokine
Series B $50M Biotechnology —
Apr 12, 2006 SkinMedica
Series E $11M Biotechnology —
Show More

Exits

Perseus-Soros Biopharmaceutical Fund has had 9 exits. Perseus-Soros Biopharmaceutical Fund most notable exits include Ambit Biosciences ,   SkinMedica

Date Company Name Exit Type Industry
May 16, 2013 Ambit Biosciences M&A Biopharma Detail
Nov 16, 2012 SkinMedica M&A Biotechnology Detail
Jan 4, 2012 Cardiokine M&A Biotechnology Detail
Oct 26, 2011 Advion Inc. M&A Biotechnology Detail
May 27, 2010 Aton Pharma M&A Biotechnology Detail
Show More
Cointime
เนื้อหา
บริษัท